2 Biotech Stocks Set to Rebound in 2026
Looking to beat the market over the next five years? Here's one strategy to adopt: Invest in stocks that have not performed well recently but boast attractive prospects.
Two intriguing corporations to consider now are Viking Therapeutics (NASDAQ: VKTX) and BioNTech (NASDAQ: BNTX). These biotech companies are somewhat risky, but after terrible performances in 2025, both could rebound this year and deliver strong returns through 2031. Allow me to explain.
Image source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Stock
€26.37
3.030%
Our community is currently high on Viking Therapeutics Inc with 4 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 25 € is below the current price of 26.37 € for Viking Therapeutics Inc, so the potential is actually -5.18%.
